Ontology highlight
ABSTRACT:
INSTRUMENT(S):
ORGANISM(S): Rattus Norvegicus (rat)
TISSUE(S): Brain
SUBMITTER: Jean ARMENGAUD
LAB HEAD: Jean Armengaud
PROVIDER: PXD050059 | Pride | 2025-10-13
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
E00839_MS21-047_Sham_F7_L_1.mgf | Mgf | |||
E00839_MS21-047_Sham_F7_L_1.raw | Raw | |||
E00840_MS21-047_Sham_F9_L_3.mgf | Mgf | |||
E00840_MS21-047_Sham_F9_L_3.raw | Raw | |||
E00841_MS21-047_Sham_F10_L_4.mgf | Mgf |
Items per page: 5 1 - 5 of 125 |
Mabondzo Aloïse A Disdier Clémence C Bouzid Amal A Larbi Khadidja Side KS Tsintzou Amalia A Maïza Auriane A Kim Boram B Costa Narciso N Harati Rania R Nguyen Anvi Laetitia AL Pruvost Alain A Galons Hervé H Oumata Nassima N Armengaud Jean J Knijnenburg Marlou M Verma Gaurav G Hagberg Henrik H Gressens Pierre P Chen Xiaodi F XF Hamoudi Rifat A RA Stonestreet Barbara S BS
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20250617 5
Hypoxic-ischemic encephalopathy (HIE) is a major cause of morbidity and mortality in newborns resulting in motor and cognitive impairment. Therapeutic hypothermia is the only treatment approved for HIE. Consequently, there is a critical requirement for additional treatments for hypoxic-ischemic (HI) brain injury because hypothermia is only partially protective. Pharmacological therapeutics are as yet not available to treat HIE. Therefore, we developed a novel trisubstituted purine-derivative dru ...[more]